Sarepta Therapeutics
SRPT
#1513
Rank
NZ$20.09 B
Marketcap
$210.36
Share price
-0.42%
Change (1 day)
45.71%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Market capitalization of Sarepta Therapeutics (SRPT)

Market cap: NZ$20.09 Billion

As of December 2024 Sarepta Therapeutics has a market cap of NZ$20.09 Billion. This makes Sarepta Therapeutics the world's 1513th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sarepta Therapeutics from 1997 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$20.09 B40.87%
2023NZ$14.26 B-20.38%
2022NZ$17.91 B56.06%
2021NZ$11.47 B-38.43%
2020NZ$18.64 B29.44%
2019NZ$14.40 B24.58%
2018NZ$11.56 B128.36%
2017NZ$5.06 B134.23%
2016NZ$2.16 B-15.95%
2015NZ$2.57 B237.13%
2014NZ$0.76 B-18.47%
2013NZ$0.93 B-5.88%
2012NZ$0.99 B667.36%
2011NZ$0.12 B-58.03%
2010NZ$0.30 B39%
2009NZ$0.22 B175.27%
2008NZ$80.68 M-31.99%
2007NZ$0.11 B-50.58%
2006NZ$0.24 B-7.08%
2005NZ$0.25 B117.04%
2004NZ$0.11 B-44.84%
2003NZ$0.21 B-14.97%
2002NZ$0.25 B-58.44%
2001NZ$0.61 B164.9%
2000NZ$0.23 B36.46%
1999NZ$0.16 B66.78%
1998NZ$0.10 B-22.45%
1997NZ$0.13 B

End of Day market cap according to different sources

On Dec 20th, 2024 the market cap of Sarepta Therapeutics was reported to be:

NZ$20.09 Billion
by Nasdaq info icon info icon
NZ$20.09 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$203.99 B 915.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.46 B-87.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.71 B-66.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.77 B-86.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$55.97 B 178.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.30 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.28 B 10.89%๐Ÿ‡บ๐Ÿ‡ธ USA